SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 31.32+1.3%Nov 11 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gerald Thomas who wrote (114)4/16/1997 6:43:00 PM
From: Douglas   of 455
 
THIS WAS A SIGNIFICANT DEVELOPMENT! Thanks for posting. I hope you didn't have to type the whole article. I printed a copy for reading and more thorough analysis later tonight. What I did notice was the comments Mr. Erck made about PRO 2000 being 10 times more potent and less irritating then nonoxynol-9. Do you know who makes nonoxynol-9? I would be interested in learning the manufacturers name and the sales figures. It was mentioned that a study is under way to determine if the compound (I assume their talking about PRO 2000) is a contraceptive candidate. What I didn't like was the talk of the Phase II studies being planned for late next year. I hope they meant late this year. I'm curious to read about the n-9 study in Cameroon. It seems to be significant.

If Procept can get the funding, I'm going to buy more shares.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext